Where does Artios's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Artios's 1 recorded funding rounds.

Premier Alternatives

Artios

Drug Discovery · Cambridge, United Kingdom · Founded 2015 · Privately Held (backing)

Developer of novel cancer treatments designed to target the deoxyribonucleic acid (DNA) damage response. Artios is based in Cambridge, United Kingdom and was founded in 2015. It was valued at $260 million at its later-stage round in Nov 2025, the last priced event on record. It has raised $385 million across 1 recorded round; the latest was an $114 million Series D in Nov 2025.

PMV mark · valuation

$260.3M

Oct 2026

Priced at

its later-stage round

Nov 2025

Total raised

$384.5M

Last round

Later Stage VC (Series D)

Nov 2025

Cap table — not yet on record

Artios's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Artios with a free account

·The complete investor list: 27 names
·Watch Artios: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Artios

Where does Artios's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Artios's 1 recorded funding rounds.